site stats

Immunic market cap

Witryna10 paź 2024 · NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX) ("Immunic" or the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology ... Witryna12 kwi 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol "IMUX" on April 15, 2024. Immunic, Inc. is a ...

Immunic, Inc. : Aegis Capital bekräftigt seine Kaufempfehlung

Witryna7 sty 2024 · Vital Therapies and Immunic will host a conference call at 8:00 a.m. ET on January 7, to discuss the proposed transaction. The conference call may be accessed by dialing +1 (855) 765-5682 for U.S ... WitrynaIMUX: Get the latest Immunic stock price and detailed information including IMUX news, historical charts and realtime prices. ... Market Cap. 44.40 M Number of Shares. 1.30 Day Low. 1.38 ... guess who back jay z https://ashleysauve.com

IMMUNIC, INC. : Konsensus der Analysten und Kursziel IMUX ...

WitrynaImmunic (IMUX) - Net assets Net assets on the balance sheet as of December 2024 : $0.11 B. According to Immunic's latest financial reports the company has $0.11 B in … Witryna1 dzień temu · Detailed statistics for Immunic, Inc. (IMUX) stock, including valuation metrics, financial numbers, share information and more. ... Immunic has a market … Witryna6 kwi 2024 · Immunic has caught the attention of market analysts with the release of positive data from the maintenance phase of its Phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC).. The company on Wednesday said data from the maintenance phase of … bound manacle location

Immunic Inc. (IMUX) Stock is expected to generate profits in the …

Category:Immunic, Inc. InvestorRoom - Stock Quote

Tags:Immunic market cap

Immunic market cap

Immunic gets a "positive surprise" from lead asset trial

Witryna7 kwi 2024 · Latest Immunic Inc Stock News. As of April 06, 2024, Immunic Inc had a $68.8 million market capitalization, putting it in the 30th percentile of companies in the Biotechnology & Medical Research industry. Immunic Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Witryna12 kwi 2024 · 5 analysts have issued 12 month price targets for Immunic's shares. Their IMUX share price forecasts range from $5.00 to $39.00. On average, they anticipate the company's stock price to reach $22.00 in the next twelve months. This suggests a possible upside of 1,554.1% from the stock's current price.

Immunic market cap

Did you know?

WitrynaImmunic started at outperform with $40 stock price target at BMO Capital Jul. 20, 2024 at 8:37 a.m. ET by Tomi Kilgore Immunic started at outperform with $59 stock price target at Wedbush WitrynaCurrent and historical total assets on balance sheet for Immunic. companies: 7,318 total market cap: $84.336 T. Global ranking; Ranking by countries. America ... The …

Witryna6 kwi 2024 · Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need – Conference Call and Webcast to be Held Today, February 9, 2024, at 11:00 am ET – NEW YORK , Feb. 9, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage … Witryna20 paź 2024 · The EIB and Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the signing of a €24.5 million financing agreement. The venture loan is intended to …

WitrynaAs of February 2024 Immunic's TTM earnings are -$83.89 M. companies: 7,303 total market cap: $84.738 T. Global ranking; Ranking by countries. America ... The … WitrynaChardan Capital Markets: Buy: $40: Show Previous Ratings Apr-13-23 08:00AM: Immunic gets a "positive surprise" from lead asset trial. News Direct. Apr-06-23 02:10PM: Immunic's (IMUX) Ulcerative Colitis Study Shows Positive Data ... Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral …

Witryna28 mar 2024 · Immunic has 4 employees across 2 locations. See insights on Immunic including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Advanced. Products. ... Market Capitalization. $64.8 M. 2024-03-28. Immunic Summary. Company summary. Overview.

Witryna12 kwi 2024 · Companies. Finance. Industry bound meaning in tagalogWitryna5 kwi 2024 · Immunic Reports Positive Data from Maintenance Phase of Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe April 5, 2024, 10:30 AM UTC Share this article bound men\\u0027s clothingWitryna10 paź 2024 · Immunic anticipates the gross proceeds from the PIPE to be approximately $60.0 million, before deducting any offering related expenses. The financing is expected to close on October 12, 2024 ... bound method dataframe.infoWitrynaFind the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 61.277M: Beta (5Y Monthly) 1.70: PE ... bound men\u0027s clothingWitrynaMarket Cap. $59.1M. Currency in USD. Quote data delayed by at least 15 minutes. Immunic, Inc. 1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 332 2559811 Email: [email protected]. Immunic AG. Lochhamer Schlag 21 82166 Gräfelfing Germany Phone: +49 89 2080 477 00 Email: [email protected]. guess who band bioWitryna7 kwi 2024 · MoneyLion Inc.’s market cap currently stands at around $133.26 million, with investors looking forward to this quarter’s earnings report slated for May 10, 2024 – May 15, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.06, which has seen fiscal year 2024 EPS growth forecast to increase to -$0.21 and about … bound mechanicWitrynaMarket Cap is a widely used stock evaluation measure. Find the latest Market Cap for Immunic (IMUX) guess who band members 2020